Issues on sedating mental patients

Posted by / 09-Dec-2017 17:31

Issues on sedating mental patients

Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.

Families and caregivers should be advised of the need for close observation and communication with the prescriber.

At dosages above 150 mg per day blocking of the antihypertensive effect of these compounds has been reported.

There has been a long standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment.

Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders.

It is not a central nervous system stimulant nor a monoamine oxidase inhibitor.

The current hypothesis is that the clinical effects are due, at least in part, to influences on the adrenergic activity at the synapses so that deactivation of norepinephrine by reuptake into the nerve terminals is prevented.

issues on sedating mental patients-69issues on sedating mental patients-9issues on sedating mental patients-85

One thought on “issues on sedating mental patients”